93 Effect of COVID vaccination on monthly migraine days 4 17. Folegatti PM, Ewer KJ, Aley PK et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet 2020; 396 (10249): 467-478. 18. Sekiguchi K, Watanabe N, Miyazaki N et al. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia 2022; 42 (3): 266-272. 19. Göbel CH, Heinze A, Karstedt S et al. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun 2021; 3 (3): fcab169. 20. Göbel CH, Heinze A, Karstedt S et al. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy 2021; 10 (2): 1309-1330. 21. Silvestro M, Tessitore A, Orologio I et al. Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine. J Clin Med 2021; 10 (24). 22. van Casteren DS, Verhagen IE, Onderwater GL et al. Sex differences in prevalence of migraine trigger factors: A cross-sectional study. Cephalalgia 2021; 41 (6): 643-648. 23. Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nature Reviews Neurology 2019; 15 (8): 483-490. 24. Kursun O, Yemisci M, van den Maagdenberg A et al. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 2021; 22 (1): 55. 25. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38 (1): 1-211. 26. Moisset X, Giraud P, Dallel R. Migraine in multiple sclerosis and other chronic inflammatory diseases. Rev Neurol (Paris) 2021; 177 (7): 816-820. 27. Aydın M, Feyzi Demir C, Arıkanoğlu A et al. Plasma Cytokine Levels in Migraineurs During and Outside of Attacks. European Journal of General Medicine 2015; 12 (4). 28. Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol 2012; 15 (Suppl 1): S15-22. 29. Ashina M, Hansen JM, Do TP et al. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 2019; 18 (8): 795-804. 30. Erdener ŞE, Kaya Z, Dalkara T. Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine. The Journal of Headache and Pain 2021; 22 (1). 31. Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain 2017; 158 (4): 543-559. 32. Caronna E, van den Hoek TC, Bolay H et al. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia 2023; 43 (1): 03331024221131337. 33. Townsend JP, Hassler HB, Sah P et al. The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2. Proceedings of the National Academy of Sciences 2022; 119 (31).
RkJQdWJsaXNoZXIy MjY0ODMw